Elevation Oncology, Inc. (ELEV) Tops Q1 EPS by 6c

Elevation Oncology, Inc. (NASDAQ: ELEV) reported Q1 EPS of ($0.23), $0.06 better than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Elevation Oncology, Inc. (ELEV) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Is Treasury selloff a major issue for stock market bulls?
• Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c